相似文献
1
The concept of pharmacologic cocaine interception as a treatment for drug abuse.
Chem Biol Interact. 2010 Sep 6;187(1-3):421-4. doi: 10.1016/j.cbi.2010.02.036. Epub 2010 Feb 26.
2
Anti-cocaine antibody and butyrylcholinesterase-derived cocaine hydrolase exert cooperative effects on cocaine pharmacokinetics and cocaine-induced locomotor activity in mice.
Chem Biol Interact. 2013 Mar 25;203(1):212-6. doi: 10.1016/j.cbi.2012.08.015. Epub 2012 Aug 31.
3
Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage.
Chem Biol Interact. 2013 Mar 25;203(1):208-11. doi: 10.1016/j.cbi.2012.08.006. Epub 2012 Aug 23.
4
Antibody-catalyzed degradation of cocaine.
Science. 1993 Mar 26;259(5103):1899-901. doi: 10.1126/science.8456315.
5
Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity.
Neuropsychopharmacology. 2014 May;39(6):1538-46. doi: 10.1038/npp.2014.3. Epub 2014 Jan 10.
6
Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse.
Expert Rev Vaccines. 2013 Mar;12(3):323-32. doi: 10.1586/erv.13.1.
7
Reward and Toxicity of Cocaine Metabolites Generated by Cocaine Hydrolase.
Cell Mol Neurobiol. 2015 Aug;35(6):819-26. doi: 10.1007/s10571-015-0175-9. Epub 2015 Mar 27.
8
Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.
CNS Neurol Disord Drug Targets. 2011 Dec;10(8):880-91. doi: 10.2174/187152711799219398.
9
Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.
PLoS One. 2012;7(8):e43536. doi: 10.1371/journal.pone.0043536. Epub 2012 Aug 17.
10
Effects of a cocaine hydrolase engineered from human butyrylcholinesterase on metabolic profile of cocaine in rats.
Chem Biol Interact. 2016 Nov 25;259(Pt B):104-109. doi: 10.1016/j.cbi.2016.05.003. Epub 2016 May 3.
引用本文的文献
1
Catalytic Antibody Blunts Carfentanil-Induced Respiratory Depression.
ACS Pharmacol Transl Sci. 2023 Apr 17;6(5):802-811. doi: 10.1021/acsptsci.3c00031. eCollection 2023 May 12.
2
Cocaine vaccine dAd5GNE protects against moderate daily and high-dose "binge" cocaine use.
PLoS One. 2020 Nov 30;15(11):e0239780. doi: 10.1371/journal.pone.0239780. eCollection 2020.
3
Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine Hydrolase Gene Therapy: A Good Laboratory Practice Preclinical Study in Mice.
Hum Gene Ther. 2020 Jan;31(1-2):70-79. doi: 10.1089/hum.2019.233. Epub 2019 Dec 19.
4
Reaction Pathway for Cocaine Hydrolase-Catalyzed Hydrolysis of (+)-Cocaine.
Theor Chem Acc. 2016 Jan;135(1). doi: 10.1007/s00214-015-1788-2. Epub 2015 Dec 28.
5
Reward and Toxicity of Cocaine Metabolites Generated by Cocaine Hydrolase.
Cell Mol Neurobiol. 2015 Aug;35(6):819-26. doi: 10.1007/s10571-015-0175-9. Epub 2015 Mar 27.
6
Plasma butyrylcholinesterase regulates ghrelin to control aggression.
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2251-6. doi: 10.1073/pnas.1421536112. Epub 2015 Feb 2.
7
Vaccines against drugs of abuse: where are we now?
Ther Adv Vaccines. 2014 Jul;2(4):106-17. doi: 10.1177/2051013614537818.
8
The future potential for cocaine vaccines.
Expert Opin Biol Ther. 2014 Sep;14(9):1271-83. doi: 10.1517/14712598.2014.920319. Epub 2014 May 16.
9
Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.
Drug Alcohol Depend. 2014 Jul 1;140:42-7. doi: 10.1016/j.drugalcdep.2014.04.003. Epub 2014 Apr 16.
10
Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity.
Neuropsychopharmacology. 2014 May;39(6):1538-46. doi: 10.1038/npp.2014.3. Epub 2014 Jan 10.
本文引用的文献
1
Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives.
Drug Alcohol Depend. 2010 Feb 1;107(1):76-9. doi: 10.1016/j.drugalcdep.2009.09.006. Epub 2009 Oct 13.
2
Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial.
Arch Gen Psychiatry. 2009 Oct;66(10):1116-23. doi: 10.1001/archgenpsychiatry.2009.128.
3
Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.
Exp Clin Psychopharmacol. 2009 Aug;17(4):205-16. doi: 10.1037/a0016469.
4
Lasting reduction of cocaine action in neostriatum--a hydrolase gene therapy approach.
J Pharmacol Exp Ther. 2009 Aug;330(2):449-57. doi: 10.1124/jpet.109.152231. Epub 2009 May 28.
5
Vaccines for cocaine abuse.
Hum Vaccin. 2009 Apr;5(4):194-9. doi: 10.4161/hv.5.4.7457. Epub 2009 Apr 20.
6
Substance abuse vaccines.
Ann N Y Acad Sci. 2008 Oct;1141:257-69. doi: 10.1196/annals.1441.027.
7
Most efficient cocaine hydrolase designed by virtual screening of transition states.
J Am Chem Soc. 2008 Sep 10;130(36):12148-55. doi: 10.1021/ja803646t. Epub 2008 Aug 19.
8
An albumin-butyrylcholinesterase for cocaine toxicity and addiction: catalytic and pharmacokinetic properties.
Chem Biol Interact. 2008 Sep 25;175(1-3):83-7. doi: 10.1016/j.cbi.2008.04.024. Epub 2008 May 1.
9
A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.
Neuropsychopharmacology. 2008 Oct;33(11):2715-25. doi: 10.1038/sj.npp.1301666. Epub 2008 Jan 16.
10
Bioscavenger for protection from toxicity of organophosphorus compounds.
J Mol Neurosci. 2006;30(1-2):145-8. doi: 10.1385/jmn:30:1:145.
Zotero 插件